Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000922423-04-000204
Filing Date
2004-02-10
Accepted
2004-02-10 16:56:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A FINAL AMENDMENT kl02012_sc13g-a.txt SC 13G/A 8709
  Complete submission text file 0000922423-04-000204.txt   10873
Mailing Address 1775 BROADWAY 26TH FLOOR NEW YORK NY 10019
Business Address 1775 BROADWAY 26TH FLOOR NEW YORK NY 10019 2127652500
GILDER GAGNON HOWE & CO LLC (Filed by) CIK: 0000902464 (see all company filings)

EIN.: 133174112 | State of Incorp.: NY | Fiscal Year End: 1231

Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Subject) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-49245 | Film No.: 04582654
SIC: 2836 Biological Products, (No Diagnostic Substances)